pyrimidinones and Pulmonary-Arterial-Hypertension

pyrimidinones has been researched along with Pulmonary-Arterial-Hypertension* in 1 studies

Other Studies

1 other study(ies) available for pyrimidinones and Pulmonary-Arterial-Hypertension

ArticleYear
Pharmacokinetics, mass balance, and metabolism of [
    Acta pharmacologica Sinica, 2023, Volume: 44, Issue:1

    TPN171 is a novel phosphodiesterase-5 (PDE5) inhibitor used to treat pulmonary arterial hypertension (PAH) and erectile dysfunction (ED), which currently is undergoing phase II clinical trials in China. In this single-center, single-dose, nonrandomized, and open design study, radiolabeled [

    Topics: Administration, Oral; Biotransformation; Feces; Humans; Male; Phosphodiesterase 5 Inhibitors; Pulmonary Arterial Hypertension; Pyrimidinones

2023